TELIX ADR Aktie

 

NEW YORK, Aug. 16, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Telix Pharmaceuticals Limited ("Telix" or the "Company") (NASDAQ: TLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The......

NEW YORK, Aug. 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Telix Pharmaceuticals Limited ("Telix" or the "Company") (NASDAQ: TLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The......

Let's see what Bell Potter has to say about this beaten down healthcare share. The post Broker says Telix shares could surge 80% higher after selloff appeared first on The Motley Fool Australia....

Greetings and welcome to HotCopper's Trends article for Tuesday 5th of August,…...

These shares are missing out on the good times today. But why? The post Why Endeavour, Platinum Capital, Telix, and TPG shares are falling today appeared first on The Motley Fool Australia....

ASX investors are punishing Telix shares today. But why? The post Why did the Telix share price just plunge 18%? appeared first on The Motley Fool Australia....

Will these results be healthy? The post CSL, Telix and more: Key reporting dates for 10 ASX 200 healthcare stocks in August appeared first on The Motley Fool Australia....

SAN FRANCISCO, July 31, 2025 /PRNewswire/ -- On July 23, 2025, investors in Telix Pharmaceuticals Limited (NASDAQ: TLX) saw the price of their American Depositary Shares significantly fall after the company revealed that it received a subpoena from the SEC. Telix's revelation has prompted......

MELBOURNE, Australia and INDIANAPOLIS, July 30, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today advises that it will release its financial results for the half-year ended 30 June 2025 on Thursday 21 August 2025....

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

Telix Pharmaceuticals (ASX:TLX), the ASX-listed healthcare major that was once almost listed…...

Investors are sending the Telix share price plunging today. But why? The post Why did the Telix share price just crash 16%? appeared first on The Motley Fool Australia....

Telix Pharmaceuticals Ltd. slumped as much as 16%, the most in 21 months, after the Australian developer of radioactive drugs said it received a subpoena from the US Securities and Exchange Commission seeking information about disclosures related to its prostate cancer therapeutic candidates....

WEST CHESTER, Pa.--(BUSINESS WIRE)--Molecular Targeting Technologies, Inc. (MTTI) today announced the appointment of Danielle Meyrick, PhD, MD, as Chief Medical Officer. Dr. Meyrick brings more than 20 years of medical research, targeted radiotherapeutic (TRT) development and leadership to MTTI. She has held Chief Medical Officer roles across radiopharmaceutical organizations including Telix Pharmaceuticals and ITM Radiopharm. Dr. Meyrick will lead MTTI's medical team to advance clinical development of lead assets, EVA101 and EVA 102 and further progress the company's radiopharmaceutical pipeline. “My career goal in the TRT area has always been to improve care and outcomes for cancer patients. I believe MTTI is an exciting company with technology that is able to deliver on this goal. Our unique EvaThera platform has demonstrated the ability to enhance delivery of radiation to tumors, minimize off-target activity and reduce dosing requirements —collectively offering a potentially safer, more effectiv...

CANBERA (dpa-AFX) - Telix Pharmaceuticals Limited (TLX) issued an update on its commercial and operational performance for the quarter ended 30 June 2025. Second quarter group revenue was approxim......

MELBOURNE, Australia and INDIANAPOLIS, July 22, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today provides an update on its commercial and operational performance for the quarter ended 30 June 2025 (Q2 2025). All figures are in USD unless stated otherwise....

Can this ASX 200 juggernaut go higher? The post JP Morgan initiates coverage of Telix Pharmaceuticals. After rising 1,667% in 5 years, is it still a buy? appeared first on The Motley Fool Australia....

MELBOURNE, Australia and INDIANAPOLIS, July 10, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that its next-generation PSMA1 PET2 imaging agent, Gozellix® (kit for the preparation of gallium-68 (68Ga) gozetotide injection), has been granted a permanent Healthcare Common Procedure Coding System (HCPCS) code by the U.S. Centers for Medicare & Medicaid Services (CMS)....

Let's see why these shares are having a good session on hump day. The post Why Botanix, Dexus, Strickland, and Telix shares are charging higher today appeared first on The Motley Fool Australia....